Sort
326,823 grants matching “clinical trial”
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,644,556Scott M Hammer · Columbia University Health Sciences · UM1 · FY2012 · AI
MICHIGAN CANCER RESEARCH CONSORTIUM
$2,644,401Philip J Stella · Saint Joseph Mercy Health System · UG1 · FY2018 · CA
Stroke with Transfusions Changing to Hydroxyurea
$2,644,329St. Jude Children'S Research Hospital · U01 · FY2005 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,644,259Gordon R. Bernard · Vanderbilt University · UL1 · FY2009 · RR
Cancer Center Support Grant
$2,644,237William L. Carroll · New York University School Of Medicine · P30 · FY2010 · CA
Cancer Center Support Grant
$2,644,237William L. Carroll · New York University School Of Medicine · P30 · FY2009 · CA
GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE
$2,644,211Stanford University · U01 · FY2001 · HL
Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium
$2,644,022Anthony J Jaslowski · St. Vincent Hospital · UG1 · FY2025 · CA
Breast and Other Cancers in the California Teachers Cohort
$2,643,925Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,643,475University Of Washington · U01 · FY2004 · HL
An Adaptation of Project Northland for Urban Youth
$2,643,335University Of Minnesota Twin Cities · R01 · FY2002 · AA
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,643,230Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Penn State Clinical and Translational Science Institute
$2,643,128Jennifer L. Kraschnewski · Pennsylvania State Univ Hershey Med Ctr · UL1 · FY2024 · TR
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,642,740Stephen A Spector · University Of California, San Diego · UM1 · FY2014 · AI
Clinical Site Monitoring Group
$2,642,284Lauren Sherwood · Rho Federal Systems Division, Inc. · UM2 · FY2019 · AI
Immune Tolerance Network-NIDDK 2024 Supplement
$2,642,000Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · UM1 · FY2024 · AI
The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes
$2,641,849Laura J Esserman · University Of California, San Francisco · P01 · FY2024 · CA
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
$2,641,256Darell D Bigner · Duke University · P01 · FY2016 · CA
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation
$2,641,189Peter Scott Heeger · Cedars-Sinai Medical Center · U01 · FY2024 · AI
SUPPLEMENTAL WORK-SARS-COV-2
$2,641,049Michael Kaytor · Humanetics Corporation · N01 · FY2020 · AI
SPRINT
$2,641,032Suzanne Oparil · University Of Alabama At Birmingham · N01 · FY2014 · HL
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$2,640,821Janet T. Holbrook · Johns Hopkins University · UG1 · FY2021 · EY
Carbon Monoxide: Novel Opportunities for Therapy
$2,640,515Mark A Perrella · Brigham And Women'S Hospital · P01 · FY2015 · HL
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,640,406University Of Washington · U01 · FY2001 · HL
Cancer Center Support Grant
$2,640,338William L. Carroll · New York University School Of Medicine · P30 · FY2008 · CA